NECLIFENSENECTAR LIFESCIENCES LTD.· PharmaceuticalsLowNeutral
Announced Thu, 20 Aug · 11:00 IST

Nectar Lifesciences 31st AGM notice, September 18, 2026 via video conferencing

Board & Shareholder Meetings View source PDFExplain this filing

NECLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.3%1-day move
₹10.57
prior close
₹10.51
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1-0.1-0.2-0.2+0.3+2.2+7.5+17.9+23.8+18.7+12.6+2.7
Up moveDown movePending
AI summary

Nectar Lifesciences has notified the 31st AGM on September 18, 2026 at 11:00 AM via video conferencing. Remote e-voting runs from September 15 (9:00 AM) to September 17 (5:00 PM), with cut-off date September 11. Business includes adoption of FY26 standalone and consolidated financial statements, re-appointment of Mr. Sanjiv Goyal as director, re-appointment of Dr. Kuldip Kumar Bhasin and Dr. Indu Pal Kaur as Independent Directors for second terms of five years each, and appointment of Dr. Gunmala Suri as Non-Executive Non-Independent Director. Share transfer books remain closed September 12 to 18, 2026.

Likely market impact

Shareholders can vote electronically from September 15 to 17. Share transfer books closed September 12 to 18. No major price impact expected from routine AGM notice.